Medical/Pharmaceuticals

ENA Members Choose Vanessa Gorman as 2027 President-elect

Secretary/treasurer, two board members also picked in annual election SCHAUMBURG, Ill., Oct. 2, 2026 /PRNewswire/ -- A believer in the power of connecting people and building the community of emergency and forensic nurses, Vanessa Gorman, DNP, MSN, RN, CCRN, FAEN, FCENA, of Australia, has been ch...

2026-10-02 04:30 2110

A Formidable Type of Childhood Cancer Gets Added to Highly Regarded Library of Treatment Recommendations

New NCCN Guidelines for Pediatric Bone Sarcoma focus on how to provide the best care possible for children and adolescents with Ewing sarcoma. PLYMOUTH MEETING, Pa., Oct. 1, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®) published the first-ever edition of NCCN Cl...

2026-10-01 21:44 3792

Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data

First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration subcutaneous formulation designed to combine BBT001's emerging profile of rapid, deep and durable clinical activity with convenient administration a...

2026-10-01 21:00 3394

Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency

* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...

2026-10-01 19:00 3077

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

SINGAPORE, Oct. 1, 2026 /PRNewswire/ -- Emerald  Clinical Trials

2026-10-01 11:00 5375

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

* Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. * The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in Lexington, Kentucky. * This partnership addresse...

2026-09-30 21:54 2105

Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC

First clinical program built on Phrontline's DLP1 branched dual-payload linker platform HANGZHOU, China and SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Phrontline Biopharma, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), today announced that the f...

2026-09-30 21:53 2769

The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24

BEIJING, Sept. 30, 2026 /PRNewswire/ -- The 94th China International Medical Equipment Fair (CMEF) and concurrent events—including ICMD, covering medical device design and manufacturing; CRS, focusing on rehabilitation and assistive technology; CECN, dedicated to elderly care and nursing; and Hea...

2026-09-30 21:16 1999

Yuyu Pharma Brings Ari's Purrfect to Amazon Accelerate 2026

Korean pharmaceutical company explores Amazon AI and seller tools to grow its U.S. feline-health brand SEOUL, South Korea, Sept. 30, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma (KRX: 000220), attended Amazon Accelerate 2026 in Seattle from September 22 to 24 to explore how Amazon'...

2026-09-30 21:00 1736

Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use for the treatmen...

2026-09-30 20:00 1568

Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use for the treatmen...

2026-09-30 20:00 1634

EASD 2026 | Ecnoglutide Demonstrates Favorable Safety Profile in Adolescents with Obesity

HANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- At the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD), Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind") today announced that its Phase 1b randomized, double-blind, placebo-controlled study of ecnoglutide, the worl...

2026-09-30 19:00 3202

43% Improvement in Hair Breakage Resistance. Scalp Redness Down 14%. Singapore's CellResearch Presents Breakthrough Hair Data at AMWC Japan

Two independent laboratory studies on PTT-6®, the cord lining stem cell active from Singapore's CellResearch Corporation, deliver standards-based evidence on hair fiber strength and scalp condition — as the global hair and scalp care category climbs from USD 93.6 billion to USD 150.5 billion by 2...

2026-09-30 17:46 949

Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma

SEONGNAM, South Korea, Sept. 30, 2026 /PRNewswire/ -- Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) adopted a positive opinion on the Orpha...

2026-09-30 17:33 1495

AsiaMedic becomes first in ASEAN to expand MRI capabilities with next-generation deep learning technology

* Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. * MR31 will enable AsiaMedic to reduce scan times and widen the range of complex examinations available to referring physicians. * The adoption builds on an established relationship b...

2026-09-30 14:56 1752

Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist

CAMBRIDGE, Mass., Sept. 30, 2026 /PRNewswire/ -- As population aging accelerates with demand for weight management continuing to expand, the market for GLP-1 receptor agonist (GLP-1RA) drugs is experiencing explosive growth. Tirzepatide, with annual sales of $36.507 billion in 2025, has become th...

2026-09-30 13:57 1676

Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access

New Rare Cancer Centre brings together expertise in rare and complex cancers, giving patients, families and referring physicians a single point of access to specialist care. SINGAPORE, Sept. 30, 2026 /PRNewswire/ -- Marking Rare Cancer Day, Tamarind Health today announced the launch of its Rare ...

2026-09-30 13:28 1826

PAAMC HK Lists Ping An AI Select ETF and Ping An Healthcare 50 Select ETF on SEHK

HONG KONG, Sept. 30, 2026 /PRNewswire/ -- Ping An of China Asset Management (Hong Kong) Company Limited ("PAAMC HK" or the "Company" ), the offshore asset management platform of Ping An Insurance (Group) Company of China, Ltd. ("Ping An Group"), is pleased to announce that the Company launches tw...

2026-09-30 09:00 1589

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

* FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating68Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting. * The designation recognizes the program's potential to address an important unmet need by enabling an imaging-first approach to ...

2026-09-30 08:26 2083

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

* Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. * With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province's leadership p...

2026-09-30 03:28 3309
1 ... 15161718192021 ... 642